£9.99 and each bottle has approximately 80 sprays.

Speak to your doctor before using VIRALEZE™ if you’re pregnant, planning on becoming pregnant, breastfeeding or planning to breastfeed.

Your nasal cavity is the primary site where cold/respiratory virus infection becomes established. VIRALEZE™ contains astodrimer sodium (SPL7013) which has been shown in laboratory to physically trap cold/respiratory viruses.*

“Spike” proteins on the surface of these viruses that meet VIRALEZE™ are trapped by astodrimer sodium. This interaction is “virucidal”, meaning that the virus can be trapped and can no longer infect cells. This provides a physical barrier to respiratory viruses. In the nasal cavity, trapped viruses would be cleared naturally through the nasal mucus.

VIRALEZE™ contains astodrimer sodium (also known as SPL7013), a compound that has been shown to physically trap cold/respiratory viruses.

VIRALEZE™ Barrier Nasal Spray creates a moisturising and protective barrier containing astodrimer sodium on the inside surface of your nose that physically traps cold/respiratory viruses. Viruses are naturally removed in the nasal mucus. 

Astodrimer sodium is included in other products approved in >40 countries, which are available for sale in UK, Europe, Japan, South east Asia, Australia, and New Zealand.

Astodrimer sodium in VIRALEZE™ is a large molecule that acts locally at site of application and does not enter the bloodstream. Astodrimer sodium has been marketed for more than 7 years in other products. If you experience nasal irritation, a nosebleed, or nasal congestion, stop using the product and speak to a healthcare professional.

You can use one spray in each nostril up to 4 times a day. If you blow your nose after spraying VIRALEZE™, you will need to reapply.

If you do need to use an allergy nasal spray and also wish to use VIRALEZE™, you should use the allergy nasal spray first, then wait 2-4 hours before using VIRALEZE™.